Skip to content

OCATA THERAPEUTICS, INC.

CIK 0001140098

← back to feed
Revenue (TTM)
$410.21K
0.0% YoY Q3 Oct 2015
Net Income (TTM)
−$21.84M
−83.6% YoY Q3 Oct 2015
EPS Diluted (TTM)
−$0.25
+33.3% YoY Q3 Oct 2015
Gross Margin
34.2%
Q3 Oct 2015
Operating Margin
-6,121.5%
Q3 Oct 2015
Net Margin
-5,324.9%
Q3 Oct 2015
Free Cash Flow (TTM)
−$14.83M
Q3 Oct 2015
Cash
$32.14M
Q3 Oct 2015
Total Debt
$6M
Q3 Oct 2015
Shares Outstanding
42.3M sh
Q3 Oct 2015

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings